Biogen Idec Expands its Neurology Pipeline by Acquiring Three Programmes from Neurimmune

By Heather Cartwright

Pharma Deals Review: Vol 2011 Issue 1 (Table of Contents)

Published: 17 Jan-2011

DOI: 10.3833/pdr.v2011.i1.1421     ISSN: 1756-7874

Section: Mergers & Acquisitions

Fulltext:

Abstract

Biogen Idec has struck a second deal with Neurimmune, this time agreeing to purchase one of the company’s subsidiaries for up to US$427...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details